Cancer: pathological nuclear reprogramming?

Nat Rev Cancer. 2014 Aug;14(8):568-73. doi: 10.1038/nrc3781. Epub 2014 Jul 17.

Abstract

The ability of stem cells to self-renew and generate different lineages during development and organogenesis is a fundamental, tightly controlled, and generally unidirectional process, whereas the 'immortality' of cancer cells could be regarded as pathological self-renewal. The molecular mechanisms that underpin the generation of induced pluripotent stem cells are remarkably similar to those that are deregulated in cancer - so much so that aberrant reprogramming is tumorigenic. The similarities also suggest that mutations in genes implicated in DNA methylation dynamics might represent a hallmark of cancers with a stem cell origin, and they highlight an alternative view of cancer that may be of clinical benefit.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cell Transformation, Neoplastic / genetics
  • Cell Transformation, Neoplastic / metabolism
  • Cellular Reprogramming*
  • DNA (Cytosine-5-)-Methyltransferases / metabolism
  • Epigenesis, Genetic
  • Humans
  • Isocitrate Dehydrogenase / metabolism
  • Neoplasms / etiology*
  • Neoplasms / metabolism
  • Neoplasms / pathology
  • Proto-Oncogene Proteins / metabolism
  • Tumor Microenvironment

Substances

  • Proto-Oncogene Proteins
  • Isocitrate Dehydrogenase
  • DNA (Cytosine-5-)-Methyltransferases